Skizofrénia: vizsgálatok itt: Szerbia
9 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleSafety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Where
- Belgrade, Niš, Novi Sad
- Életkor
- 5 év to 17 év
- People
- 300 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06229210 · EU 2023-507068-38-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Where
- Belgrade, Kovin, Kragujevac, Niš, Novi Kneževac
- Életkor
- 55 év and over
- People
- 370 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Belgrade, Gornja Toponica, Kovin, Kragujevac, Novi Sad
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Kragujevac
- Életkor
- 55 év to 90 év
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - 3. fázisTaking peopleNBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Where
- Belgrade, Gornja Toponica, Kragujevac
- Életkor
- 18 év to 65 év
- People
- 284 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07105098 · EU 2025-521215-39-00 - 3. fázisTaking peopleNBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Where
- Belgrade, Gornja Toponica, Kragujevac
- Életkor
- 18 év to 65 év
- People
- 600 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07114874 · EU 2025-521216-19-00 - 3. fázisTaking peopleEfficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Where
- Gornja Toponica, Kragujevac
- Életkor
- 18 év to 65 év
- People
- 560 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07227818 - 4. fázisTaking peopleClinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
- Where
- Belgrade
- Életkor
- 16 év to 70 év
- People
- 2500 worldwide
- Run by
- Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00 - 3. fázisTaking peopleEfficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- Where
- Belgrade, Novi Sad
- Életkor
- 13 év to 17 év
- People
- 330 worldwide
- Run by
- Gedeon Richter Plc.
See details and how to joinNCT03817502 · EU 2024-513194-44-00